Robust antibody response after the third mRNA coronavirus vaccination in Japanese hemodialysis patients

Robust antibody response after the third mRNA coronavirus vaccination in Japanese hemodialysis patients

Abstract Background Hemodialysis patients have chronic kidney disease, are often elderly, and have many complications such as hypertension, type 2 diabetes, cardiac disease, and cerebrovascular disease. Therefore, hemodialysis patients infected with COVID-19 are prone to severe disease. Vaccination...

Full description

Bibliographic Details
Main Authors: Ryoichi Miyazaki, Kyoko Miyagi, Misaki Yoshida, Yasunori Suzuki, Shinya Hibino
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Renal Replacement Therapy
Subjects:
COVID-19 prevention
mRNA vaccine
Japanese hemodialysis patients
Online Access:https://doi.org/10.1186/s41100-023-00491-2

Similar Items

Similar Items